CytRx Announces Positive Results of Arimoclomol in Preclinical Stroke Recovery Studies
...For more information, visit www.cytrx.com. Worcester, Massachusetts based rxi Pharmaceuticals Corporation is a biopharmaceutical research and development...ll be on neurodegenerative diseases, oncology, type 2 diabetes and obesity. rxi has licenses to a diverse series of early patents and patent applications t...CytRx Announces Clinical Results from Its Rising Multiple Dose Trial with Arimoclomol for ALS
...ation on the Company, visit www.cytrx.com. About rxi Pharmaceuticals Corporation Worcester, Massachusetts-based rxi Pharmaceuticals Corporation, a majority-owned subs...e diseases, oncology, type 2 diabetes and obesity. rxi has licenses to a diverse series of early patents ...CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
...ation on the Company, visit www.cytrx.com. About rxi Pharmaceuticals Corporation Worcester, Massachusetts-based rxi Pharmaceuticals Corporation, a majority-owned subs...e diseases, oncology, type 2 diabetes and obesity. rxi has licenses to a diverse series of early patents ...ZyGEM Appoints Leading Biotechnology Expert to Head Clinical Advisory Board
...ously, he held a series of positions of increasing responsibility at Amgen and Bristol-Myers Squibb. Dr. Ahn also serves on the Boards of Directors of rxi Pharmaceuticals and Access Pharmaceuticals. He received B.A. and M.B.A. degrees from Chaminade University of Honolulu and holds a Ph.D. from the Unive...